MannKind Corp
MNKD5.250USD
-0.170-3.14%
收盤 11/11, 16:00（美東）報價延遲15分鐘
1.61B總市值
55.14本益比TTM
關於 MannKind Corp 公司
MannKind Corporation 是一家生物製藥公司。該公司專注於爲內分泌和罕見肺病患者開發和商業化吸入治療產品。其技術包括 Technosphere 乾粉配方和 Dreamboat 吸入裝置，可將藥物輸送到肺部深處，在那裏藥物可以局部發揮作用或進入全身循環。其產品包括 Afrezza（人胰島素）吸入粉和 V-Go 可穿戴胰島素輸送裝置。Afrezza（人胰島素）吸入粉是一種吸入胰島素，用於增強糖尿病成人患者的血糖控制。V-Go 可穿戴胰島素輸送裝置爲需要胰島素的成人提供皮下胰島素輸注。其罕見肺病產品線包括 Tyvaso DPI（曲前列尼爾）吸入粉，用於治療肺動脈高壓 (PAH) 和與間質性肺病相關的肺動脈高壓 (PH-ILD)。
MannKind Corp簡介
公司代碼MNKD
公司名稱MannKind Corp
上市日期Jul 28, 2004
CEODr. Michael E. Castagna, Pharm.D.
員工數量407
證券類型Ordinary Share
年結日Jul 28
公司地址1 Casper Street
城市DANBURY
上市交易所NASDAQ Global Market Consolidated
國家United States of America
郵編06810
電話18186615000
網址https://mannkindcorp.com/
公司代碼MNKD
上市日期Jul 28, 2004
CEODr. Michael E. Castagna, Pharm.D.
MannKind Corp公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Michael E. Castagna, Pharm.D.
Dr. Michael E. Castagna, Pharm.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
1.71M
-6.09%
Dr. David B. Thomson, J.D., Ph.D.
Dr. David B. Thomson, J.D., Ph.D.
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
621.22K
-5.74%
Mr. Steven B. Binder
Mr. Steven B. Binder
Director
Director
452.01K
-17.33%
Mr. Dominic (Nick) Marasco
Mr. Dominic (Nick) Marasco
President, Endocrine Business Unit
President, Endocrine Business Unit
333.43K
+32.31%
Mr. Anthony C. (Tony) Hooper
Mr. Anthony C. (Tony) Hooper
Independent Director
Independent Director
201.15K
+14.19%
Mr. Ronald J. Consiglio
Mr. Ronald J. Consiglio
Independent Director
Independent Director
118.43K
--
Ms. Jennifer Grancio
Ms. Jennifer Grancio
Independent Director
Independent Director
110.70K
--
Dr. Sabrina Kay
Dr. Sabrina Kay
Independent Director
Independent Director
107.03K
--
Ms. Christine Mundkur, J.D.
Ms. Christine Mundkur, J.D.
Independent Director
Independent Director
27.68K
--
Dr. James Samuel Shannon, M.D.
Dr. James Samuel Shannon, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
24.46K
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Michael E. Castagna, Pharm.D.
Dr. Michael E. Castagna, Pharm.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
1.71M
-6.09%
Dr. David B. Thomson, J.D., Ph.D.
Dr. David B. Thomson, J.D., Ph.D.
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
621.22K
-5.74%
Mr. Steven B. Binder
Mr. Steven B. Binder
Director
Director
452.01K
-17.33%
Mr. Dominic (Nick) Marasco
Mr. Dominic (Nick) Marasco
President, Endocrine Business Unit
President, Endocrine Business Unit
333.43K
+32.31%
Mr. Anthony C. (Tony) Hooper
Mr. Anthony C. (Tony) Hooper
Independent Director
Independent Director
201.15K
+14.19%
Mr. Ronald J. Consiglio
Mr. Ronald J. Consiglio
Independent Director
Independent Director
118.43K
--
收入明細
單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
業務USD
名稱
營收
佔比
Product sales
44.68M
58.38%
Royalties
31.23M
40.81%
Services
621.00K
0.81%
地區USD
名稱
營收
佔比
United States
76.53M
100.00%
業務
地區
業務USD
名稱
營收
佔比
Product sales
44.68M
58.38%
Royalties
31.23M
40.81%
Services
621.00K
0.81%
股東統計
更新時間: 8月15日 週五
更新時間: 8月15日 週五
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
7.68%
The Vanguard Group, Inc.
5.72%
State Street Investment Management (US)
3.50%
Geode Capital Management, L.L.C.
2.48%
Nitorum Capital, L.P.
2.28%
其他
78.34%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
7.68%
The Vanguard Group, Inc.
5.72%
State Street Investment Management (US)
3.50%
Geode Capital Management, L.L.C.
2.48%
Nitorum Capital, L.P.
2.28%
其他
78.34%
股東類型
持股股東
佔比
Investment Advisor
23.00%
Investment Advisor/Hedge Fund
17.68%
Hedge Fund
10.68%
Research Firm
3.31%
Individual Investor
1.72%
Bank and Trust
0.62%
Pension Fund
0.32%
Venture Capital
0.03%
Insurance Company
0.03%
其他
42.62%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
473
171.20M
55.75%
-15.78M
2025Q2
477
184.37M
60.10%
+2.23M
2025Q1
482
184.47M
60.73%
+2.52M
2024Q4
470
175.08M
57.68%
+5.91M
2024Q3
459
161.03M
58.24%
+6.62M
2024Q2
442
145.29M
52.88%
-4.76M
2024Q1
433
140.98M
52.03%
-8.31M
2023Q4
422
141.98M
52.59%
-12.51M
2023Q3
418
148.17M
55.00%
-3.06M
2023Q2
412
143.59M
53.56%
-12.28M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
23.58M
7.69%
+2.13M
+9.93%
Jun 30, 2025
The Vanguard Group, Inc.
18.10M
5.9%
+838.68K
+4.86%
Jun 30, 2025
State Street Investment Management (US)
10.75M
3.5%
+1.28M
+13.47%
Jun 30, 2025
Geode Capital Management, L.L.C.
7.62M
2.48%
+831.48K
+12.25%
Jun 30, 2025
Nitorum Capital, L.P.
7.01M
2.29%
-774.19K
-9.94%
Jun 30, 2025
Two Sigma Investments, LP
5.91M
1.93%
-1.19M
-16.80%
Jun 30, 2025
Avoro Capital Advisors LLC
5.85M
1.91%
-2.90M
-33.14%
Jun 30, 2025
Millennium Management LLC
4.48M
1.46%
-1.34M
-23.03%
Jun 30, 2025
Qube Research & Technologies Ltd
4.07M
1.33%
+825.61K
+25.48%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
4.05M
1.32%
+528.66K
+15.00%
Jun 30, 2025
查看更多
持股ETF
更新時間: 11月6日 週四
更新時間: 11月6日 週四
機構名稱
佔比
Invesco Biotechnology & Genome ETF
3.53%
ALPS Medical Breakthroughs ETF
1.01%
Invesco NASDAQ Future Gen 200 ETF
0.57%
VictoryShares Small Cap Free Cash Flow ETF
0.43%
Global X Aging Population ETF
0.31%
SPDR S&P Biotech ETF
0.29%
SPDR S&P Kensho New Economies Composite ETF
0.26%
Timothy Plan US Small Cap Core ETF
0.22%
ProShares Ultra Nasdaq Biotechnology
0.17%
Invesco Nasdaq Biotechnology ETF
0.16%
查看更多
Invesco Biotechnology & Genome ETF
佔比3.53%
ALPS Medical Breakthroughs ETF
佔比1.01%
Invesco NASDAQ Future Gen 200 ETF
佔比0.57%
VictoryShares Small Cap Free Cash Flow ETF
佔比0.43%
Global X Aging Population ETF
佔比0.31%
SPDR S&P Biotech ETF
佔比0.29%
SPDR S&P Kensho New Economies Composite ETF
佔比0.26%
Timothy Plan US Small Cap Core ETF
佔比0.22%
ProShares Ultra Nasdaq Biotechnology
佔比0.17%
Invesco Nasdaq Biotechnology ETF
佔比0.16%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
